180 Wealth Advisors LLC Sells 1,367 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

180 Wealth Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 64.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 762 shares of the healthcare conglomerate’s stock after selling 1,367 shares during the quarter. 180 Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $386,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Delta Financial Group Inc. boosted its holdings in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares in the last quarter. First PREMIER Bank boosted its stake in UnitedHealth Group by 7.0% in the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after buying an additional 18 shares in the last quarter. Genesee Capital Advisors LLC raised its stake in shares of UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after acquiring an additional 18 shares in the last quarter. Jmac Enterprises LLC grew its holdings in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the last quarter. Finally, Matrix Private Capital Group LLC lifted its stake in UnitedHealth Group by 3.6% in the second quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 19 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $543.76 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $500.41 billion, a price-to-earnings ratio of 35.42, a P/E/G ratio of 1.53 and a beta of 0.62. The company has a 50 day simple moving average of $554.45 and a two-hundred day simple moving average of $563.12. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on UNH shares. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.